Vered Stearns

发表

MR-image-based tissue analysis and its clinical applications

Jianhua Xuan, Yue Joseph Wang, Kun Huang, 2002, SPIE Medical Imaging.

Activation of diverse signaling pathways by oncogenic PIK3CA mutations

Akhilesh Pandey, Xinyan Wu, Heng Zhu, 2014, Nature Communications.

Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.

Yusuke Nakamura, Daniel J Schaid, Richard M Weinshilboum, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Monitoring of neoadjuvant chemotherapy using multiparametric, 23Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer

David A. Bluemke, Michael A. Jacobs, Antonio C. Wolff, 2011, Breast Cancer Research and Treatment.

P1-12-20: The Safety and Tolerability of Vorinostat in Combination with Lapatinib in Advanced Solid Tumors.

Edward A. Sausville, Saranya Chumsri, Vered Stearns, 2011 .

Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancer.

Zhe Zhang, Richard Zellars, Saranya Chumsri, 2010, Clinical breast cancer.

Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer

Antonio C. Wolff, Leslie Cope, Vered Stearns, 2014, Clinical Cancer Research.

Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board.

Hyunseok Kang, Christopher D Gocke, David M Loeb, 2017, JCO precision oncology.

Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients

Zeruesenay Desta, Lang Li, Vered Stearns, 2010, Journal of clinical pharmacology.

Phase 2 study investigating the safety, efficacy, and surrogate biomarkers of response to 5-azacitidine (5-AZA) and entinostat in advanced breast cancer.

Nita Ahuja, Adam Brufsky, Stephen B. Baylin, 2014 .

Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways

Akhilesh Pandey, Xinyan Wu, Arivusudar Marimuthu, 2015, Oncotarget.

Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: Implication for optimization of breast cancer treatment

Zeruesenay Desta, David A Flockhart, Lang Li, 2006, Clinical pharmacology and therapeutics.

Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer

Todd C. Skaar, David A. Flockhart, Daniel F. Hayes, 2016, The oncologist.

Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells.

Nita Ahuja, Yi Cai, Yoon-Young Jang, 2012, Cancer cell.

Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study

Leslie Cope, Nita Ahuja, Adam Brufsky, 2016, Clinical Cancer Research.

Increasing Physical Activity Amongst Overweight and Obese Cancer Survivors Using an Alexa-Based Intelligent Agent for Patient Coaching: Protocol for the Physical Activity by Technology Help (PATH) Trial

Jennifer Schrack, Lawrence Appel, Vered Stearns, 2018, JMIR research protocols.

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx.

Fabrice Andre, Vered Stearns, R. Bast, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer

Doron Lipson, Gary L Rosner, Christopher D Gocke, 2016, Clinical Cancer Research.

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

David A. Flockhart, Daniel F. Hayes, Richard M. Weinshilboum, 2005, Journal of the National Cancer Institute.

CYP2D6 Polymorphisms and Tamoxifen Metabolism: Clinical Relevance

Vered Stearns, V. Stearns, M. Higgins, 2010, Current oncology reports.

Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.

David A Flockhart, Vered Stearns, Daniel F Hayes, 2008, The American journal of psychiatry.

Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood

Ben H. Park, Frank Diehl, Joel Greshock, 2012, Clinical Cancer Research.

Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer.

Leslie Cope, Christopher B Umbricht, Vered Stearns, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation.

Steven Piantadosi, Vered Stearns, Barbara Biedrzycki, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Crossover from one aromatase inhibitor (AI) to another in the Exemestane and Letrozole Pharmacogenetics (ELPh) trial.

Nicholas J Seewald, Kelley M Kidwell, Norah Lynn Henry, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tamoxifen metabolism and its effect on endocrine treatment of breast cancer.

Susanne Briest, Vered Stearns, V. Stearns, 2009, Clinical advances in hematology & oncology : H&O.

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.

Andreas Makris, Wolfgang Eiermann, Vered Stearns, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.

Zeruesenay Desta, David A Flockhart, Vered Stearns, 2003, Journal of the National Cancer Institute.

Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

Andres Forero, James N. Ingle, Vered Stearns, 2013, Clinical Cancer Research.

Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients

Norah Lynn Henry, Steffi Oesterreich, Todd C. Skaar, 2009, The Pharmacogenomics Journal.

Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer

Zhe Zhang, David A. Flockhart, Daniel F. Hayes, 2012, Breast Cancer Research and Treatment.

Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI

Paul A. Bottomley, David A. Bluemke, Katarzyna J. Macura, 2007, Breast Cancer Research and Treatment.

Epigenetic Regulation as a New Target for Breast Cancer Therapy

Qun Zhou, Vered Stearns, N. Davidson, 2007, Cancer investigation.

Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer

Steffi Oesterreich, Todd C. Skaar, David A. Flockhart, 2013, Breast Cancer Research and Treatment.

Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial.

Karen A Gelmon, James N Ingle, Vered Stearns, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.

Ian Krop, Fabrice Andre, Vered Stearns, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant radiation use in older women with early-stage breast cancer at Johns Hopkins

Vered Stearns, Susan Harvey, A. Cimino-Mathews, 2016, Breast Cancer Research and Treatment.

Multiparametric and Multimodality Functional Radiological Imaging for Breast Cancer Diagnosis and Early Treatment Response Assessment.

Katarzyna J Macura, Ronald Ouwerkerk, David A Bluemke, 2015, Journal of the National Cancer Institute. Monographs.

In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole.

Zeruesenay Desta, David A Flockhart, Mark J Ratain, 2010, British journal of clinical pharmacology.

Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update.

Vered Stearns, J. Griggs, E. Winer, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Needs assessments can identify scores on HRQOL questionnaires that represent problems for patients: an illustration with the Supportive Care Needs Survey and the QLQ-C30

Sydney M. Dy, Antonio C. Wolff, Albert W. Wu, 2010, Quality of Life Research.